AstraZeneca Pharmaceuticals LP
2871 articles about AstraZeneca Pharmaceuticals LP
-
AstraZeneca PLC Pays $135 Million to Buy Equal Say Over Amylin Pharmaceuticals, Inc. Drugs
8/9/2012
-
Founded by Enlight Biosciences, KNODE Partners With AstraZeneca PLC and Other Partners
8/2/2012
-
IntelliPharmaCeutics Settles Patent Litigation With AstraZeneca PLC Concerning Generic Seroquel XR®
7/31/2012
-
Bristol-Myers Squibb Company & AstraZeneca PLC Release: Pooled Analysis Showed Onglyza® (saxagliptin) Provided Improvements in Key Measures of Blood Sugar Control in Adults With Type 2 Diabetes at High Risk for CV Disease
7/30/2012
-
Assay Depot, Inc. Partners With AstraZeneca PLC to Launch Virtual Research Laboratory
7/30/2012
-
AstraZeneca PLC Sales Hit Hard by Generic Competition
7/26/2012
-
AstraZeneca PLC Starts New Study of Heart Drug Versus Rival
7/18/2012
-
AstraZeneca PLC's Ex-CEO Forfeits 2012 Bonus
7/16/2012
-
AstraZeneca PLC Claims Neuroscience Shake-Up is Paying Off ; May Advance at Least 8 Drugs to Final Tests by 2015
7/16/2012
-
Genpact and AstraZeneca PLC Win Outsourcing Center and SSON Awards
7/12/2012
-
AstraZeneca PLC Buys Link Medicine Neuroscience Assets; Enters Alzheimer's Pact
7/12/2012
-
AstraZeneca PLC and Leading Academic Scientists to Collaborate on Alzheimer's Disease Research
7/12/2012
-
AstraZeneca PLC Loses Fight Over Generic Seroquel
7/11/2012
-
AstraZeneca PLC, Bristol-Myers Squibb Company Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc.
7/3/2012
-
AstraZeneca PLC, GlaxoSmithKline Eyes More Deals
7/2/2012
-
AstraZeneca PLC and Cellworks Collaborate to Find New Treatment for Tuberculosis
7/2/2012
-
Merck & Co., Inc., AstraZeneca PLC Venture Stays Intact for at Least Two More Years
6/27/2012
-
Novartis AG, AstraZeneca PLC Win EU Drug Okays; Pfizer Inc. Loses Out
6/22/2012
-
Troubled AstraZeneca PLC Should Consider Merging With Abbvie: Analysts
6/21/2012
-
AstraZeneca PLC-Palatin Technologies Halts Phase I Obesity Trial
6/20/2012